Effect of Gender on Pancreatic Disease

Colm J. O'Loughlin, Umaprasanna S. Karnam, Jamie S Barkin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter discusses pancreatic lesions that occur more frequently in men or women, evaluates the mechanisms by which they occur, and reviews their clinical course and therapy. Sex steroid hormones (SSH) including estrogens, progestagens, and androgens are responsible for sexual differentiation, and their major target organs are the mammary glands, urogenital tract, bone, cardiovascular and central nervous systems. Epidemiologic, clinical, and biochemical findings have shown the relationship between gender and prevalence of some tumors of the pancreas, the effect of pregnancy on insulin and glucose metabolism, and the identification of SSH receptors in pancreatic tissue. The study of gender-specific pancreatic lesions provides clues regarding their origin, development, tumoral behavior, prognosis, and more specific hormonal therapy. The varying effects of sex steroid hormones (SSH) in development and growth of pancreatic neoplasms may be related to the mechanism affecting carcinogenesis, and may be multifactorial and/or different for each hormone. Clinical trials designed to evaluate the response of cancer of the pancreas to hormonal therapy have been inconclusive.

Original languageEnglish
Title of host publicationPrinciples of Gender-Specific Medicine
PublisherElsevier Inc.
Pages454-462
Number of pages9
Volume1
ISBN (Print)9780124409057
DOIs
StatePublished - Dec 1 2004

Fingerprint

Pancreatic Diseases
Gonadal Steroid Hormones
Pancreatic Neoplasms
Sex Differentiation
Steroid Receptors
Neurology
Progestins
Human Mammary Glands
Growth and Development
Metabolism
Androgens
Tumors
Pancreas
Bone
Estrogens
Carcinogenesis
Therapeutics
Central Nervous System
Clinical Trials
Hormones

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

O'Loughlin, C. J., Karnam, U. S., & Barkin, J. S. (2004). Effect of Gender on Pancreatic Disease. In Principles of Gender-Specific Medicine (Vol. 1, pp. 454-462). Elsevier Inc.. https://doi.org/10.1016/B978-012440905-7/50311-X

Effect of Gender on Pancreatic Disease. / O'Loughlin, Colm J.; Karnam, Umaprasanna S.; Barkin, Jamie S.

Principles of Gender-Specific Medicine. Vol. 1 Elsevier Inc., 2004. p. 454-462.

Research output: Chapter in Book/Report/Conference proceedingChapter

O'Loughlin, CJ, Karnam, US & Barkin, JS 2004, Effect of Gender on Pancreatic Disease. in Principles of Gender-Specific Medicine. vol. 1, Elsevier Inc., pp. 454-462. https://doi.org/10.1016/B978-012440905-7/50311-X
O'Loughlin CJ, Karnam US, Barkin JS. Effect of Gender on Pancreatic Disease. In Principles of Gender-Specific Medicine. Vol. 1. Elsevier Inc. 2004. p. 454-462 https://doi.org/10.1016/B978-012440905-7/50311-X
O'Loughlin, Colm J. ; Karnam, Umaprasanna S. ; Barkin, Jamie S. / Effect of Gender on Pancreatic Disease. Principles of Gender-Specific Medicine. Vol. 1 Elsevier Inc., 2004. pp. 454-462
@inbook{e3d0a9bdc13c417a8735d621b86b51ef,
title = "Effect of Gender on Pancreatic Disease",
abstract = "This chapter discusses pancreatic lesions that occur more frequently in men or women, evaluates the mechanisms by which they occur, and reviews their clinical course and therapy. Sex steroid hormones (SSH) including estrogens, progestagens, and androgens are responsible for sexual differentiation, and their major target organs are the mammary glands, urogenital tract, bone, cardiovascular and central nervous systems. Epidemiologic, clinical, and biochemical findings have shown the relationship between gender and prevalence of some tumors of the pancreas, the effect of pregnancy on insulin and glucose metabolism, and the identification of SSH receptors in pancreatic tissue. The study of gender-specific pancreatic lesions provides clues regarding their origin, development, tumoral behavior, prognosis, and more specific hormonal therapy. The varying effects of sex steroid hormones (SSH) in development and growth of pancreatic neoplasms may be related to the mechanism affecting carcinogenesis, and may be multifactorial and/or different for each hormone. Clinical trials designed to evaluate the response of cancer of the pancreas to hormonal therapy have been inconclusive.",
author = "O'Loughlin, {Colm J.} and Karnam, {Umaprasanna S.} and Barkin, {Jamie S}",
year = "2004",
month = "12",
day = "1",
doi = "10.1016/B978-012440905-7/50311-X",
language = "English",
isbn = "9780124409057",
volume = "1",
pages = "454--462",
booktitle = "Principles of Gender-Specific Medicine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Effect of Gender on Pancreatic Disease

AU - O'Loughlin, Colm J.

AU - Karnam, Umaprasanna S.

AU - Barkin, Jamie S

PY - 2004/12/1

Y1 - 2004/12/1

N2 - This chapter discusses pancreatic lesions that occur more frequently in men or women, evaluates the mechanisms by which they occur, and reviews their clinical course and therapy. Sex steroid hormones (SSH) including estrogens, progestagens, and androgens are responsible for sexual differentiation, and their major target organs are the mammary glands, urogenital tract, bone, cardiovascular and central nervous systems. Epidemiologic, clinical, and biochemical findings have shown the relationship between gender and prevalence of some tumors of the pancreas, the effect of pregnancy on insulin and glucose metabolism, and the identification of SSH receptors in pancreatic tissue. The study of gender-specific pancreatic lesions provides clues regarding their origin, development, tumoral behavior, prognosis, and more specific hormonal therapy. The varying effects of sex steroid hormones (SSH) in development and growth of pancreatic neoplasms may be related to the mechanism affecting carcinogenesis, and may be multifactorial and/or different for each hormone. Clinical trials designed to evaluate the response of cancer of the pancreas to hormonal therapy have been inconclusive.

AB - This chapter discusses pancreatic lesions that occur more frequently in men or women, evaluates the mechanisms by which they occur, and reviews their clinical course and therapy. Sex steroid hormones (SSH) including estrogens, progestagens, and androgens are responsible for sexual differentiation, and their major target organs are the mammary glands, urogenital tract, bone, cardiovascular and central nervous systems. Epidemiologic, clinical, and biochemical findings have shown the relationship between gender and prevalence of some tumors of the pancreas, the effect of pregnancy on insulin and glucose metabolism, and the identification of SSH receptors in pancreatic tissue. The study of gender-specific pancreatic lesions provides clues regarding their origin, development, tumoral behavior, prognosis, and more specific hormonal therapy. The varying effects of sex steroid hormones (SSH) in development and growth of pancreatic neoplasms may be related to the mechanism affecting carcinogenesis, and may be multifactorial and/or different for each hormone. Clinical trials designed to evaluate the response of cancer of the pancreas to hormonal therapy have been inconclusive.

UR - http://www.scopus.com/inward/record.url?scp=84902054953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902054953&partnerID=8YFLogxK

U2 - 10.1016/B978-012440905-7/50311-X

DO - 10.1016/B978-012440905-7/50311-X

M3 - Chapter

AN - SCOPUS:84902054953

SN - 9780124409057

VL - 1

SP - 454

EP - 462

BT - Principles of Gender-Specific Medicine

PB - Elsevier Inc.

ER -